For human clinical trials, there is a growing movement to replace the term "study subject" with a terminology that is more respectful and recognizes the agency of those who consent to be treated and have their data collected. The term "participant”, rather than "study subject", is now used in ICH E6 R3 guidelines. The TransCelerate Biopharma Common Protocol Template states that "participant" may be used in patient-facing documents.
Japan Clinical Informatization for Chronic Diseases Related to Lifestyle
Japan Clinical Informatization for Chronic Diseases Related to Lifestyle
Japan Clinical Informatization for Chronic Diseases Related to Lifestyle
Japan Clinical Informatization for Chronic Diseases Related to Lifestyle
Japan Clinical Informatization for Chronic Diseases Related to Lifestyle
Japan Clinical Informatization for Chronic Diseases Related to Lifestyle
Pagination
- Previous page
- Page 21 / 24
- Next page